Minerco, Inc. (MINE) Stock On Watch As The Magic Mushroom Boom is Spreading Nationwide

Over the past five years, a wave of academic research has emerged which supports the notion that psychedelic-inspired medicines are effective and often superior treatments for things like addiction, ADHD, depression and anorexia.

Oregon voters last week approved a ballot initiative legalizing use of psilocybin — the psychedelic component of “magic” mushrooms — in a therapeutic setting.

Although some western US cities, including Denver, Oakland and Santa Cruz, had effectively removed threat of arrest or prosecution for possession of mushrooms last year, Oregon’s statewide vote could signal things to come in California, which could be the next state to relax laws outlawing possession of psilocybin mushrooms, ayahuasca, MDMA, and other psychedelic drugs.

Impressed with the latest improvements, State Sen. Scott Wiener (D-San Francisco) said Tuesday he plans to introduce legislation that would decriminalize psychedelics after the state Legislature reconvenes next month.

According to the National Institute of Mental Health, more than 17 million people in the U.S. and 300 million people worldwide have experienced major depression.

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.

The antidepressant effect of the psilocybin—the active compound in so-called magic mushrooms—was about four times greater than is typically seen in traditional antidepressants currently on the market.

Minerco, Inc. (OTC: MINE), is the world’s first publicly traded company specializing in growing, research, production and distribution of psilocybin mushrooms and marketing worldwide.

Last month, Minerco announced that the company is looking to open facility in Ann Arbor Michigan. MINE is now poised to take advantage of the Midwest market.

This is an exciting development for us to be one the the first companies to open a facility in the Midwest. Magic Mushrooms can heal so many people and provide a first mover advantage for our company ,” stated Julius Jenge, Chief Executive Officer of Minerco, Inc. Our commitment to research, production and distribution of psilocybin mushrooms, is now a reality, Minerco can be poised to help PSTD and work closer with Doctors in Ann Arbor. Michigan being the second largest medical Cannabis state in USA gives us an additional opportunity to thrive for our shareholders.

Recent

The Covid-19 pandemic has brought to light a few penny stocks: (OPTI) Optec International, Inc., (LRSV) LinkResPet (ADMQ) ADM Endeavors Inc. and (SSET) Starstream...

The Covid-19 pandemic has brought the global economy to levels not seen in years, but it has also brought to light a...

As Calls for New Treatments and Testing Methods for COVID-19 have increased Globally, Halberd Corporation (OTC: HALB) should be on Top of Everyone’s Watchlist

The US added more than 157,000 new Covid-19 cases Wednesday, according to Johns Hopkins University. The US Centers for Disease Control and...

Minerco, Inc. (MINE) Stock On Watch As The Magic Mushroom Boom is Spreading Nationwide

Over the past five years, a wave of academic research has emerged which supports the notion that psychedelic-inspired medicines are effective and...

Patient Investors Can Prosper in The Long Term by initiating Positions in Solar Power-Oriented Stocks such as Solar Integrated Roofing Corporation (SIRC)

There’s a variety of appealing ways in which investors can soak up the sun. With solar powered products becoming even more affordable,...

As Joe Biden’s presidential Victory Could Lead to more Calls for Cannabis Decriminalization, American Premium Water Corp. (HIPH) is Expanding its Global Footprint

Legal cannabis has never looked more likely in the United States. Investors are clearly hopeful with a Democrat in the White House....

The pandemic isn’t likely to go away anytime soon, and that makes AllStar Health Brands Inc. (ALST) a relatively safe investment during the pandemic

There are now more than 48 million worlwide and over 9 million cases of COVID-19 confirmed in...

Joe Biden Win: A Huge Victory for the Renewable Energy Industry

For the first time ever, in April 2019, renewable energy outpaced coal by providing 23% of US power generation, compared to coal’s...

3 Sub Penny Stocks To Watch This Month: Nutra Pharma Corporation (NPHC), American Premium Water (HIPH) and American Green, Inc. (ERBB)

Nutra Pharma Corporation (OTC: NPHC) operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies...

5 Virtual Reality Stocks To Watch This Month: Himax Technologies, Inc. (HIMX), Gaensel Energy, Inc. (GEGR), Facebook Inc. (FB), Intel Corporation (INTC) and All...

Virtual reality (VR) in the gaming market was valued at USD 7.7 billion in 2019 and is projected to reach USD 42.50...

2 Therapeutic Stocks To Watch This Month: Frequency Therapeutics, Inc. (FREQ) and Electromedical Technologies, Inc. (EMED)

Physical therapy continues to be a growing field with a positive outlook as a career path. It is a $30 billion industry with...

4 Cannabis Stocks To Watch This Month: TransAtlantic Capital Inc. , CV Sciences, Inc., Canopy Growth Corporation and Aurora Cannabis Inc.

The growth in cannabis sales appears to have brought some relief to cannabis stocks, which have been going through a rough period....

The Coronavirus isn’t Stopping Splash Beverage Group, Inc. (SBEV) from Growing

Global Rehydration drink sales reached a value of $53.01 billion in 2018 and are expected to grow at a CAGR of 7.20%...

3 Healthcare Stocks Weathering The Coronavirus Storm Right Now: Progressive Care, Inc. (RXMD), Moderna, Inc. (MRNA) and Gilead Sciences (GILD)

The biotech industry is expected to balloon to a massive $727B in the next five years. And along the way, we’ll also see new...